Study to compile a register of the Liver Cancer Center Heidelberg (LCCH-Register).

Study to compile a register of the Liver Cancer Center Heidelberg (LCCH-Register). - LCCH-Register

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00019901

Enrollment

6000

Registered

2020-01-03

Start date

2020-04-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C23 C22 C24

Interventions

Group 1: The LCCH-Register is a common database that collects and combines the domain knowledge available at the Liver Cancer Center Heidelberg (LCCH), e.g. in the fields of surgery, gastroenterology

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Tumor of the hepatobiliary system 2) Ability to consent 3) Patient information and written consent

Exclusion criteria

Exclusion criteria: 1) Inability to consent 2) Revocation of consent

Design outcomes

Primary

Measure	Time frame
The aim of the project is the creation of a patient registry (i.e. LCCH-Register) for standardized reporting and systematic long-term data collection (retrospective and prospective) of patients with tumors of the hepatobiliary system. The LCCH-Register will help physicians to identify patients who can participate in clinical trials and to record and evaluate clinical, pathological, and molecular parameters of tumors of the hepatobiliary system. This more efficient interdisciplinary information flow will help to improve patient care in the long term.	—

Measure

Time frame

The aim of the project is the creation of a patient registry (i.e. LCCH-Register) for standardized reporting and systematic long-term data collection (retrospective and prospective) of patients with tumors of the hepatobiliary system. The LCCH-Register will help physicians to identify patients who can participate in clinical trials and to record and evaluate clinical, pathological, and molecular parameters of tumors of the hepatobiliary system. This more efficient interdisciplinary information flow will help to improve patient care in the long term.

—

Secondary

Measure	Time frame
(1) Determination of an extended standard dataset for patients with tumors of the hepatobiliary system (2) Provide a structured documentation method for medical findings (3) Structuring and collection of retrospective and prospective care data from patients with tumors of the hepatobiliary system in one registry (4) Make the collected care data available for long-term research / development of new research questions	—

Measure

Time frame

(1) Determination of an extended standard dataset for patients with tumors of the hepatobiliary system (2) Provide a structured documentation method for medical findings (3) Structuring and collection of retrospective and prospective care data from patients with tumors of the hepatobiliary system in one registry (4) Make the collected care data available for long-term research / development of new research questions

—

Countries

Germany

Contacts

Public ContactChristoph Springfeld

Universitätsklinikum Heidelberg

Christoph.Springfeld@med.uni-heidelberg.de06221 5638552

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026